RACHEL KIRMER: Open Payments
NPI 1336888130 · GARDEN CITY, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,023 in 51 payments from 17 companies in 2025. Trend: 2023 $0 · 2024 $47 · 2025 $1,023
Food & beverage: $843Education: $180
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $183 |
| Janssen Biotech, Inc. | 8 | $143 |
| SANOFI-AVENTIS U.S. LLC | 1 | $99 |
| E.R. Squibb & Sons, L.L.C. | 5 | $93 |
| UCB, Inc. | 4 | $75 |
| Novartis Pharmaceuticals Corporation | 3 | $63 |
| LEO Pharma Inc. | 3 | $57 |
| Amgen Inc. | 3 | $47 |
| HARMONY BIOSCIENCES LLC | 1 | $47 |
| GENZYME CORPORATION | 2 | $36 |
Products named: DUPIXENT, TREMFYA, SKYRIZI, Sotyktu, RINVOQ, Bimzelx, OTEZLA, COSENTYX.
Industry payments across KS — which companies pay providers there.
